Ginkgo Bioworks Holdings Number of Employees 2020-2022 | DNA

Ginkgo Bioworks Holdings number of employees from 2020 to 2022. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
Ginkgo Bioworks Holdings Annual Number of Employees
2021 641
2020 2
2019
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.841B $0.314B
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $171.964B 10.49
GSK (GSK) United Kingdom $71.240B 8.93
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.458B 19.56
Myovant Sciences (MYOV) United Kingdom $2.593B 0.00
Arcus Biosciences (RCUS) United States $2.495B 37.46
Biohaven (BHVN) United States $1.127B 0.00
Emergent Biosolutions (EBS) United States $0.589B 4.63
Zymeworks (ZYME) Canada $0.487B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.267B 0.00
Enzo Biochem (ENZ) United States $0.095B 0.00
SQZ Biotechnologies (SQZ) United States $0.052B 0.00
Gelesis Holdings (GLS) United States $0.025B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00